BioCryst Legal Chief Sells $1.37M in Stock After Exercising Options
Alane P. Barnes, Chief Legal Officer of BioCryst Pharmaceuticals Inc., executed an automatic insider transaction plan on March 16, 2026, exercising options to acquire 150,000 shares and selling 150,000 shares of common stock. The sale totaled $1,372,500 at a weighted average price of $9.15, while the option exercise cost $826,500. Following the act…